Davidson Kempner Capital Management’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Davidson Kempner Capital Management’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-87,649	Closed	-$14K	–	491
2022 Q4	$14K	Hold	87,649	–	–	﹤0.01%	345
2022 Q3	$6K	Hold	87,649	–	–	﹤0.01%	497
2022 Q2	$13K	Hold	87,649	–	–	﹤0.01%	501
2022 Q1	$24K	Hold	87,649	–	–	﹤0.01%	571
2021 Q4	$64K	Hold	87,649	–	–	﹤0.01%	516
2021 Q3	$56K	Hold	87,649	–	–	﹤0.01%	474
2021 Q2	$66K	Buy	+87,649	New	+$66.8K	﹤0.01%	550

Other funds holding PKBOW

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Davidson Kempner Capital Management's PKBOW Position: Q1 2023 in Review

Davidson Kempner Capital Management sold out of Peak Bio, Inc. Warrant (PKBOW) in Q1 2023, closing a stake of 87,649 shares — an estimated $14K sold.

Davidson Kempner Capital Management first reported a position in PKBOW in Q2 2021 and held it in 7 quarters. The position peaked at $66K in Q2 2021. 5 funds tracked by Wall St. Rank hold PKBOW as of Q1 2023.

Davidson Kempner Capital Management reported no remaining Peak Bio, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
Davidson Kempner Capital Management sold 87,649 Peak Bio, Inc. Warrant shares in Q1 2023, an estimated $14K.
Davidson Kempner Capital Management first reported a position in Peak Bio, Inc. Warrant in Q2 2021 and held it in 7 quarters.
Davidson Kempner Capital Management's Peak Bio, Inc. Warrant position peaked at $66K in Q2 2021.
5 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q1 2023.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2023, filed 15 May 2023.